Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

PERFORMANCE OF αSYNUCLEIN RT-QUIC IN RELATION TO NEUROPATHOLOGICAL STAGING OF LEWY BODY DISEASE

medRxiv(2022)10.1101/2022.05.05.22274567Source: DataRank Database

PERFORMANCE OF αSYNUCLEIN RT-QUIC IN RELATION TO NEUROPATHOLOGICAL STAGING OF LEWY BODY DISEASE is a research paper published in medRxiv (2022). On theSindex it has a DataRank of 0.341. It has been cited 4 times, with 3 citing works in its 1-hop citation network.

N/A

0.341DataRank · unranked

Scored on demand from live citation data

Open Access4 citations · 3 citing works in its network

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)OA: greenTopics (30)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 71%Citation Network 29%

Base Score Contribution

0.241

From this paper's citation signal

Citation Network Contribution

0.0991

From 3 citing papers with measurable signal

Learn more about DataRank methodology →

Top 3 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 3 citers.

Detecting Misfolded α‐Synuclein in Blood Years before the Diagnosis of Parkinson's Disease
Movement Disorders202462 citations59 referencesContributes 0.070
Comparison of biospecimens for α‐synuclein seed amplification assays in Parkinson's disease: A systematic review and network meta‐analysis
European Journal of Neurology202338 citations89 referencesContributes 0.041
Right anterior insula ASL hypoperfusion as a diagnostic biomarker of prodromal and mild dementia with Lewy bodies: preliminary evidence using a Bayesian approach
GeroScience20241 citations132 referencesContributes 0.005

Authors (10)

Christina D. Orrú ORCID,Geidy E. Serrano ORCID,Douglas Galasko ORCID,Andrew G. Hughson ORCID,Bradley R. Groveman ORCID

Live enrichment

PubMed:26207759 OpenAlex:https://openalex.org/W4281291633

National Institutes of Health

Grant: 5P30AG072980-02

Arizona Alzheimer's Disease Research Center

Knut and Alice Wallenberg Foundation

Grant: unidentified

unidentified

National Institutes of Health

Grant: 2P30AG019610-11

Education and Information Transfer Core

National Institutes of Health

Grant: 5U24NS072026-03

National Brain and Tissue Resource for Parkinson's Disease and Related Disorders

National Institutes of Health

Grant: 5P30AG062429-03

UCSD Alzheimer's Disease Research Centers P30

greenLicense: CC BY

repositoryhttps://www.medrxiv.org/content/medrxiv/early/2022/05/07/2022.05.05.22274567.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2022.05.05.22274567

repositoryhttps://doi.org/10.1101/2022.05.05.22274567

https://doi.org/10.1186/s40478-022-01388-7

Fields of Study

Parkinson's Disease Mechanisms and TreatmentsBotulinum Toxin and Related Neurological DisordersAlzheimer's disease research and treatments0303 health sciences03 medical and health sciences

Keywords

CohortDementia with Lewy bodiesMedicinePathologyLewy bodyInternal medicineParkinson's diseaseDementiaDiseaseBrain ChemistryLewy Body DiseaseSynucleinopathiesResearchBrainParkinson diseaseCerebrospinal fluidDiagnosisalpha-SynucleinHumansLewy BodiesAutopsyNeurology. Diseases of the nervous systemLewy body dementiaRC346-429Biomarkers

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being